Gilead Sciences to Present at Two Upcoming Investor Conferences

FOSTER CITY, Calif., Feb 23, 2011 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the RBC Capital Markets' Healthcare Conference and the Citi Global Healthcare Conference, both taking place in New York.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, and Robin Washington, Gilead's Chief Financial Officer, will provide an overview of the company at the RBC conference on Wednesday, March 2 at 11:00 a.m. Eastern Standard Time (EST) and the Citi conference on Thursday, March 3 at 11:00 a.m. EST.

To access the live webcasts via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com orcall the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.Susan Hubbard, 650-522-5715Investor Relations